ISPOR - HTA86 Establishing the Multi-Criteria Decision Analysis (MCDA) Framework to Assess the Value of Orphan Drugs in China: From the Perspective of Stakeholders and the Public

HTA86 Establishing the Multi-Criteria Decision Analysis (MCDA) Framework to Assess the Value of Orphan Drugs in China: From the Perspective of Stakeholders and the Public

Abstract

Authors

D. Chen Y. Xiang M. Hu

Full Text Cite This Article

Back to Volume 26, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now